Lilly, Boehringer retrench in Germany on proposed health spending cuts

June 4, 2026 11:13 AM EDTUpdated 12:21 PM PharmaManufacturing Ger­many’s health-spend­ing plan has con­se­quences as Lil­ly, Boehringer scale back Ayisha Sharma News Reporter Back­lash is brew­ing against a sweep­ing over­haul of Ger­many’s health in­sur­ance sys­tem as Eli Lil­ly and Boehringer In­gel­heim slash in­vest­ment in the coun­try. The drug­mak­ers’ … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER